-
My Account
In App
My Account
BSE Live
Oct 27, 13:30Prev. Close
460.80
Open Price
455.05
Bid Price (Qty.)
458.25 (50)
Offer Price (Qty.)
458.95 (20)
NSE Live
Oct 27, 13:30Prev. Close
460.55
Open Price
460.00
Bid Price (Qty.)
458.70 (100)
Offer Price (Qty.)
458.85 (232)
| Key Financial Ratios of Akums Drugs Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | |
| Per Share Ratios | ||||
| Basic EPS (Rs.) | 10.76 | -11.56 | 8.77 | |
| Diluted EPS (Rs.) | 10.76 | -11.56 | 8.77 | |
| Cash EPS (Rs.) | 13.10 | -9.28 | 10.86 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 150.57 | 10.06 | 21.77 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 150.57 | 10.06 | 21.77 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 85.68 | 100.94 | 89.95 | |
| PBDIT/Share (Rs.) | 17.16 | -2.27 | 23.63 | |
| PBIT/Share (Rs.) | 14.57 | -4.56 | 21.53 | |
| PBT/Share (Rs.) | 13.57 | -7.19 | 10.51 | |
| Net Profit/Share (Rs.) | 10.52 | -11.56 | 8.77 | |
| Profitability Ratios | ||||
| PBDIT Margin (%) | 20.02 | -2.25 | 26.26 | |
| PBIT Margin (%) | 17.01 | -4.51 | 23.93 | |
| PBT Margin (%) | 15.84 | -7.12 | 11.68 | |
| Net Profit Margin (%) | 12.27 | -11.45 | 9.74 | |
| Return on Networth / Equity (%) | 6.98 | -114.99 | 40.26 | |
| Return on Capital Employed (%) | 9.39 | -4.09 | 22.03 | |
| Return on Assets (%) | 5.99 | -7.89 | 6.62 | |
| Total Debt/Equity (X) | 0.00 | 1.57 | 0.47 | |
| Asset Turnover Ratio (%) | 0.55 | 0.72 | 0.69 | |
| Liquidity Ratios | ||||
| Current Ratio (X) | 2.69 | 1.06 | 1.05 | |
| Quick Ratio (X) | 2.04 | 0.74 | 0.65 | |
| Inventory Turnover Ratio (X) | 4.46 | 4.83 | 4.20 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||
| Enterprise Value (Cr.) | 6,914.18 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 5.27 | 0.00 | 0.00 | |
| EV/EBITDA (X) | 26.32 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 5.54 | 0.00 | 0.00 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 3.15 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 5.54 | 0.00 | 0.00 | |
| Earnings Yield | 0.02 | 0.00 | 0.00 |
22.08.2025
Akums Drugs P Standalone June 2025 Net Sales at Rs 332.44 crore, up 4.78% Y-o-Y
27.05.2025
Akums Drugs P Consolidated March 2025 Net Sales at Rs 1,055.55 crore, up 11.79% Y-o-Y
27.05.2025
Akums Drugs P Standalone March 2025 Net Sales at Rs 328.75 crore, up 10.19% Y-o-Y
12.02.2025
Akums Drugs & P Standalone December 2024 Net Sales at Rs 337.41 crore, down 11.94% Y-o-Y
22.08.2025
Akums Drugs P Standalone June 2025 Net Sales at Rs 332.44 crore, up 4.78% Y-o-Y
27.05.2025
Akums Drugs P Consolidated March 2025 Net Sales at Rs 1,055.55 crore, up 11.79% Y-o-Y
27.05.2025
Akums Drugs P Standalone March 2025 Net Sales at Rs 328.75 crore, up 10.19% Y-o-Y
12.02.2025
Akums Drugs & P Standalone December 2024 Net Sales at Rs 337.41 crore, down 11.94% Y-o-Y
